Oppenheimer & CO Inc Tyra Biosciences, Inc. Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
A detailed history of Oppenheimer & CO Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 76,806 shares of TYRA stock, worth $1.26 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
76,806
Previous 70,488
8.96%
Holding current value
$1.26 Million
Previous $1.13 Million
60.16%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding TYRA
# of Institutions
97Shares Held
43.6MCall Options Held
338KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$170 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$105 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$76.2 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$72.1 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$66.3 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $686M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...